Gross profit margin of Sinovac Biotech Ltd. 2017-2022
Sinovac's annual revenue increased almost 40 times in 2021.
In 2022, the gross profit margin of Sinovac Biotech Ltd., one of China's leading vaccine producers, dropped to 57.8 percent. Thanks to the development and wide adaption of CoronaVac, the company's COVID-19 vaccine,